A number of other research analysts have also weighed in on HIVE. Canaccord Genuity Group raised their target price on HIVE Blockchain Technologies from $5.50 to $7.00 and gave the company a “buy” rating in a report on Monday, August 29th. Canaccord Genuity Group lifted their price objective on shares of HIVE Blockchain Technologies from $5.50 to $7.00 in a report on Monday, August 29th. Finally, HC Wainwright raised their price target on shares of HIVE Blockchain Technologies from $6.00 to $7.00 and gave the company a “buy” rating in a research report on Thursday, August 18th.
HIVE Blockchain Technologies Stock Performance
NASDAQ HIVE opened at $4.79 on Thursday. The company has a market cap of $393.97 million and a P/E ratio of 95.80. The company has a fifty day simple moving average of $4.45 and a 200 day simple moving average of $6.40. The company has a current ratio of 3.11, a quick ratio of 3.11 and a debt-to-equity ratio of 0.11. HIVE Blockchain Technologies has a 12-month low of $2.82 and a 12-month high of $28.00.
Institutional Investors Weigh In On HIVE Blockchain Technologies
An institutional investor recently bought a new position in HIVE Blockchain Technologies stock. State Street Corp purchased a new position in shares of HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE – Get Rating) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 336,731 shares of the company’s stock, valued at approximately $1,007,000. State Street Corp owned about 0.41% of HIVE Blockchain Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 8.08% of the company’s stock.
HIVE Blockchain Technologies Company Profile
HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. It engages in the mining and sale of digital currencies, including Ethereum, Ethereum Classic, and Bitcoin. The company was formerly known as Leeta Gold Corp. and changed its name to HIVE Blockchain Technologies Ltd.
- Get a free copy of the StockNews.com research report on HIVE Blockchain Technologies (HIVE)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.